Xenia Geronicola Trapali
Overview
Explore the profile of Xenia Geronicola Trapali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
43
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koros C, Simitsi A, Papagiannakis N, Bougea A, Prentakis A, Papadimitriou D, et al.
J Parkinsons Dis
. 2023 Jul;
13(5):811-818.
PMID: 37424476
Background: The role of blood uric acid as a biomarker in symptomatic motor PD has been increasingly established in the literature. Objective: Our present study assessed the role of serum...
2.
Pachi I, Koros C, Simitsi A, Papadimitriou D, Bougea A, Prentakis A, et al.
Parkinsonism Relat Disord
. 2021 Aug;
91:1-8.
PMID: 34425330
Introduction: Higher prevalence of motor and non-motor features has been observed in non-manifesting mutation carriers of Parkinson's Disease (PD) compared to Healthy Controls (HC). The aim was to detect the...
3.
Bougea A, Koros C, Papagiannakis N, Simitsi A, Prentakis A, Papadimitriou D, et al.
J Parkinsons Dis
. 2021 Mar;
11(2):633-640.
PMID: 33682725
Background: Previous studies have highlighted serum uric acid as a putative idiopathic Parkinson's disease (iPD) biomarker. Only one study, so far, showed higher levels of serum uric acid in leucine-rich...
4.
Koros C, Simitsi A, Papagiannakis N, Bougea A, Prentakis A, Papadimitriou D, et al.
Parkinsonism Relat Disord
. 2021 Jan;
84:1-4.
PMID: 33508700
Introduction: Blood uric acid represents an important biomarker in sporadic Parkinson's disease (PD). Whether uric acid levels change in genetic forms of PD is beginning to be assessed. The aim...
5.
Koros C, Simitsi A, Prentakis A, Papagiannakis N, Bougea A, Pachi I, et al.
Parkinsonism Relat Disord
. 2020 Jul;
77:36-42.
PMID: 32615498
Introduction: It has been reported that early onset Parkinson's Disease (PD) patients have a less profound dopaminergic degeneration. The aim of the current study was to determine whether there are...
6.
Koros C, Simitsi A, Papadimitriou D, Bougea A, Prentakis A, Papagiannakis N, et al.
J Parkinsons Dis
. 2020 Mar;
10(2):481-487.
PMID: 32176655
Background: Blood uric acid level represents an emerging biomarker in Parkinson's disease (PD). Whether uric acid levels change in genetic forms of PD is just beginning to be explored. Objective:...
7.
Koros C, Simitsi A, Prentakis A, Beratis I, Papadimitriou D, Kontaxopoulou D, et al.
Mov Disord
. 2018 Oct;
33(11):1734-1739.
PMID: 30288781
Background: The p.A53T point mutation in the α-synuclein gene (SNCA) is a rare but highly relevant cause of autosomal dominant Parkinson's disease (PD). Objectives: The objective of this study was...
8.
Bougea A, Koros C, Stamelou M, Simitsi A, Papagiannakis N, Antonelou R, et al.
Parkinsonism Relat Disord
. 2016 Dec;
35:82-87.
PMID: 28012952
Introduction: The p.A53T point mutation in SNCA, the alpha-synuclein gene, has been linked to a rare dominant form of Parkinson's disease (PD). Methods: Here, we describe two apparently unrelated cases...